Home Creative PIONEERING CELL & ANTIBODY-BASED CANCER THERAPEUTICS LEARN MORE Media & News Alphageneron to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th, 2021 June 25, 2021 Read More Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide February 4, 2021 Read More Harvard Square, One Mifflin Place, Suite 400Cambridge, MA 02138
Alphageneron to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th, 2021 June 25, 2021 Read More
Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide February 4, 2021 Read More
